We analyze a nonlinear q-voter mannequin with stochastic noise, interpreted within the social context as independence, on a duplex community. The dimensions of the foyer q (i.e., the stress group) is an important parameter that adjustments the conduct of the system. The q-voter mannequin has been utilized on multiplex networks, and it has been proven that the character of the part transition is dependent upon the variety of ranges within the multiplex community in addition to on the worth of q.
The first purpose of this research is to look at part transition character within the case when on every stage of the community the foyer measurement is totally different, leading to two parameters q1 and q2. In a system of a duplex clique (i.e., two totally overlapped full graphs) we discover proof of successive part transitions when a steady part transition is adopted by a discontinuous one or two consecutive discontinuous part transitions seem, relying on the parameter. When analyzing this technique, we even encounter mixed-order (or hybrid) part transition. The statement of successive part transitions is a brand new amount in binary state opinion formation fashions and we present that our analytical issues are totally supported by Monte-Carlo simulations.
Extra notes on the publication of the Narrative, Zoology and Notes from a Journal of Analysis into the Pure Historical past of the Voyage of H.M.S. Samarang and its penalties for the nomenclature of decapod crustaceans and different taxa
Captain Edward Belcher was instructed by the Lords of the Admiralty to conduct a Surveying Expedition of the assorted coasts and islands within the Jap Seas utilizing H.M.S. Samarang. Throughout this voyage from 1843-1846, Assistant-Surgeon Arthur Adams, made a big contribution to the gathering of pure historical past specimens, and along with fellow officers J. Richards and W. Browne, he ready quite a few drawings utilized by Belcher for instance the Narrative of the voyage.
Later, Adams collaborated with Adam White (an Assistant within the Zoological Department of the British Museum) to explain the Samarang Crustacea, revealed collectively with Lovell Reeve on the Samarang Mollusca, edited the Zoology of the voyage of H.M.S. Samarang and was the creator of Notes from a Journal of the Pure Historical past which was revealed within the Narrative of the voyage by Belcher. In his Pure Historical past, Adams offered detailed accounts on a number of the crustaceans collected with formal descriptions of species new to science thereby making these names accessible. The historical past, nomenclature and validity of the crustacean species cited on this work is mentioned and a listing of the accessible names is tabulated.
The New Biology as an Instance of Newspeak: The Case of Polish Zoology, 1948-1956.
The “New Biology” that arose within the Jap Block throughout Stalinist occasions was primarily based on the thought of the heritability of acquired traits. In rejecting the paradigm of Mendelian chromosome genetics in addition to science-based farming, the New Biology led to a deterioration of scientific life and the free trade of concepts. In imposing Lysenko’s concepts onto zoology, the New Biology adopted the totalitarian language of Newspeak, which dominated public discourse in communist international locations.
Newspeak had a number of defining parts: a restricted dictionary, sturdy valuations, binary oppositions, the magical operate of language, militarization, and ritualization of language. On this research, the idea of Newspeak is used to investigate major sources (publications, speeches, and convention discussions) in Polish zoology within the interval between 1948 and 1956. As soon as the observe of Newspeak started to wane, so did the New Biology that had been based on this particular ritualistic language.
Ludwig Heinrich Bojanus (1776-1827) on Gall’s craniognomic system, zoology, and comparative anatomy.
Most of what was recognized about Franz Joseph Gall’s (1758-1828) organology or Schädellehre previous to the 1820s got here from secondary sources, together with letters from correspondents, promotional supplies, transient newspaper articles about his lecture-demonstrations, and editions and translations of some lengthier works of various high quality in German. Doctor Ludwig Heinrich Bojanus (1776-1827) practiced in Vienna’s Basic Hospital in 1797-1798; attended a few of Gall’s public lectures; and, in 1801-1802, grew to become one of many first physicians to supply detailed reviews on Gall’s rising organology in French and English, respectively.
Though Bojanus thought of the human thoughts to be indivisible and didn’t fully agree with Gall’s assumption that the mind consists of numerous impartial organs chargeable for varied schools, he offered helpful info and considerate commentary on Gall’s views. Moreover, he defended Gall towards the cost that his type of pondering would result in materialism and cautiously predicted that the brand new system can be fruitful for growing and stimulating essential new analysis in regards to the mind and thoughts.
Doxorubicin |
|||
A3966-S | ApexBio | Evaluation Sample | EUR 22 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
ADC-P-013 | Creative Biolabs | unit | Ask for price |
Doxorubicin |
|||
HY-15142A | MedChemExpress | 100mg | EUR 258 |
Doxorubicin |
|||
T1456-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin |
Doxorubicin HCl |
|||
20-abx184016 | Abbexa |
|
|
Doxorubicin HCl |
|||
abx076623-25ml | Abbexa | 25 ml | EUR 187.5 |
Doxorubicin HCl |
|||
abx076623-5ml | Abbexa | 5 ml | EUR 118.75 |
Doxorubicin 10mM |
|||
TG4120 | TopoGen | 0.25ml | EUR 187.2 |
Doxorubicin-SMCC |
|||
406622 | MedKoo Biosciences | 1.0mg | EUR 90 |
Doxorubicin-MVCP |
|||
T31567-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-SMCC |
|||
T15161-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin HCl, 100mg |
|||
R2531 | ACTGene | 100mg | EUR 1080.79 |
Doxorubicin HCl, 100mg |
|||
R2531-100mg | ACTGene | each | EUR 1560 |
Doxorubicin HCl, 10mg |
|||
R2531-10mg | ACTGene | each | EUR 236.4 |
Adriamycin (Doxorubicin) |
|||
E1KS1208 | EnoGene | 10mg | EUR 276 |
Doxorubicin Free Base |
|||
100960 | MedKoo Biosciences | 10.0mg | EUR 150 |
Doxorubicin Hydrochloride |
|||
20-abx076623 | Abbexa |
|
|
Doxorubicin hydrochloride |
|||
100280 | MedKoo Biosciences | 100.0mg | EUR 150 |
Doxorubicin Hydrochloride |
|||
40410004-1 | Glycomatrix | 10 mg | EUR 136.34 |
Doxorubicin Hydrochloride |
|||
40410004-2 | Glycomatrix | 25 mg | EUR 273.17 |
Doxorubicin Hydrochloride |
|||
D558000 | Toronto Research Chemicals | 100mg | EUR 136 |
Description: 25316-40-9 |
Doxorubicin hydrochloride |
|||
ADC-P-014 | Creative Biolabs | unit | Ask for price |
Hydroxyacetyl Doxorubicin |
|||
H415946 | Toronto Research Chemicals | 25mg | EUR 15000 |
Doxorubicin (hydrochloride) |
|||
HY-15142 | MedChemExpress | 100mg | EUR 176.4 |
Doxorubicin hydrochloride |
|||
GA4969-100MG | Glentham Life Sciences | 100 mg | EUR 217.2 |
Doxorubicin hydrochloride |
|||
GA4969-10MG | Glentham Life Sciences | 10 mg | EUR 93.6 |
Doxorubicin hydrochloride |
|||
GA4969-25MG | Glentham Life Sciences | 25 mg | EUR 117.6 |
Doxorubicin hydrochloride |
|||
GA4969-50MG | Glentham Life Sciences | 50 mg | EUR 151.2 |
Doxorubicin Hydrochloride |
|||
SIH-390-10MG | Stressmarq | 10 mg | EUR 129 |
Description: Apoptosis Inducer |
Doxorubicin Hydrochloride |
|||
SIH-390-50MG | Stressmarq | 50 mg | EUR 465 |
Description: Apoptosis Inducer |
Doxorubicin hydrochloride |
|||
T1020-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
TNC00267 | ChemNorm | 20mg | Ask for price |
Doxorubicin (Adriamycin) HCl |
|||
A1832-10 | ApexBio | 10 mg | EUR 36 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-100 | ApexBio | 100 mg | EUR 128 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-25 | ApexBio | 25 mg | EUR 52 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Antitumour antibiotic,inhibits TOPO II. |
4'O-Benzyl Doxorubicin |
|||
B788120 | Toronto Research Chemicals | 100mg | EUR 1200 |
Description: 677017-23-1 |
Doxorubicin hydrochloride, 98% |
|||
GP9056-100 | Glentham Life Sciences | 100 | EUR 140.2 |
Doxorubicin hydrochloride, 98% |
|||
GP9056-25 | Glentham Life Sciences | 25 | EUR 56.1 |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1g | TargetMol Chemicals | 1g | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
Doxorubicin hydrochloride USP |
|||
D005-10MG | TOKU-E | 10 mg | EUR 117.34 |
Description: C27H29NO11•HCl |
Doxorubicin hydrochloride USP |
|||
D005-25MG | TOKU-E | 25 mg | EUR 234.67 |
Description: C27H29NO11•HCl |
7-Deoxy Doxorubicin Aglycone (> 75%) |
|||
D232910 | Toronto Research Chemicals | 10mg | EUR 299 |
Description: 38554-25-5 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-10 | Glentham Life Sciences | 10 | EUR 47.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-100 | Glentham Life Sciences | 100 | EUR 150.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-25 | Glentham Life Sciences | 25 | EUR 67.2 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-50 | Glentham Life Sciences | 50 | EUR 95 |
PEGylated Liposomal Doxorubicin- 2 mg |
|||
PHPC002DX | ProFoldin | 2 mg | EUR 140.62 |
Description: This product includes 1 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
PEGylated Liposomal Doxorubicin- 20 mg |
|||
PHPC020DX | ProFoldin | 20 mg | EUR 358.62 |
Description: This product includes 10 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
Doxorubicin, Hydrochloride Salt [CAS# 25316-40-9] |
|||
D-4000 | LC LABORATORIES | 25 mg | EUR 40 |
Doxorubicin-hydrazone-caproyl-maleimide |
|||
D558040 | Toronto Research Chemicals | 100mg | EUR 1800 |
Description: 151038-96-9 |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
IHUHELADTLW500UG | Innovative research | each | EUR 327 |
Description: Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
IHUHELADTLN200UG | Innovative research | each | EUR 427 |
Description: Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
Doxorubicin-hydrazone-caproyl-maleimide Hydrochloride (~80%) |
|||
D399610 | Toronto Research Chemicals | 250mg | EUR 150 |
7,8-Desacetyl-9,10-dehydro Daunorubicinone (~90%)(Doxorubicin Impurity) |
|||
D288680 | Toronto Research Chemicals | 10mg | EUR 4281 |
Description: 1159977-24-8 |
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Doxorubicin Stimulated |
|||
HCL-2010 | Alpha Diagnostics | 100ug | EUR 255.6 |
6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione (Doxorubicin Impurity) |
|||
T795210 | Toronto Research Chemicals | 10mg | EUR 244 |
Description: 64845-67-6 |
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Doxorubicin Stimulated |
|||
HCL-2004 | Alpha Diagnostics | 100ug | EUR 270 |
Des-[(4-Amino-2,3,6-trideoxy-hexapyranosyl)oxy)-1-methyl] 2-Carboxylate Doxorubicin |
|||
D558001 | Toronto Research Chemicals | 100mg | EUR 4500 |
Doxorubicin.HCl |
|||
1527-5 | Biovision | each | EUR 183.6 |
Doxorubicinol (>90%) |
|||
D558025 | Toronto Research Chemicals | 2.5mg | EUR 1929 |
Doxorubicinol |
|||
T25349-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinol |
|||
T25349-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinol |
Doxorubicinone |
|||
D559070 | Toronto Research Chemicals | 25mg | EUR 244 |
Description: 24385-10-2 |
Doxorubicinone |
|||
T29673-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinone |
Doxorubicinone |
|||
T29673-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinone |
3-N-Carboxylic Acid 1-beta-D-Glucuronide-[4-(methyl)phenyl]carbamate Ester Doxorubicin |
|||
C177855 | Toronto Research Chemicals | 50mg | EUR 11200 |
Description: 211364-63-5 |
7,8,9,10-Dehydro Doxorubicinone (~70%) |
|||
D229580 | Toronto Research Chemicals | 10mg | EUR 5528 |
Description: 1159977-23-7 |
Bromo Didehydro Doxorubicinone |
|||
B682880 | Toronto Research Chemicals | 25mg | EUR 1200 |
Description: 63626-06-2 |
Doxorubicinol hydrochloride |
|||
T40736-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinol hydrochloride |
|||
T40736-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicinol hydrochloride |
Doxorubicinolone, 90%(Mixture of Diastereomers) |
|||
D559050 | Toronto Research Chemicals | 0.5mg | EUR 1774 |
Description: 56149-23-6 |
7-Deoxy Doxorubicinol Aglycone (Mixture of Diastereomers) 85% |
|||
D232898 | Toronto Research Chemicals | 0.5mg | EUR 2405 |
Description: 187105-52-8 |
Doxorubicinol Hydrochloride (>90%) (Mixture of diastereomers) |
|||
D558020 | Toronto Research Chemicals | 10mg | EUR 141 |
(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione-d6(Doxorubicin Impurity) |
|||
A630407 | Toronto Research Chemicals | 5mg | EUR 800 |
Anti-EGFR-doxorubicin ADC |
|||
ADC-W-600 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-EGFR monoclonal antibody conjugated via a linker to a doxorubicin |
Anti-CD22-DIBO-doxorubicin ADC |
|||
ADC-W-339 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-CD22 monoclonal antibody conjugated via a DIBO linker to a doxorubicin |
Anti-TNFRSF8 (cAC10)-DIBO-doxorubicin ADC |
|||
ADC-W-406 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cAC10) conjugated via a DIBO linker to a doxorubicin |
Anti-ERBB2 (Trastuzumab)-NGM-doxorubicin ADC |
|||
ADC-W-412 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a NGM linker to adoxorubicin |
Anti-EGFR (cetuximab)-SMCC-Doxorubicin ADC |
|||
ADC-W-504 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-EGFR monoclonal antibody (cetuximab) conjugated via a SMCC linker to Doxorubicin |
Anti-EpCAM (MOC31)-hydrazone-Doxorubicin ADC |
|||
ADC-W-581 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-EPCAM monoclonal antibody (MOC31) conjugated via a hydrazone linker to Doxorubicin |
DOXO-EMCH |
|||
A3372-10 | ApexBio | 10 mg | EUR 214 |
Description: Prodrug of doxorubicin |
DOXO-EMCH |
|||
A3372-100 | ApexBio | 100 mg | EUR 1956 |
Description: The (6-maleimidocaproyl) hydrazone derivative of doxorubicin (INNO-206), formerly known as DOXO-EMCH, is a prodrug of the anticancer agent doxorubicin which selectively binds to the cys34 of circulating albumin and accumulates in solid tumors due to passive targeting[1]. |
DOXO-EMCH |
|||
A3372-2 | ApexBio | 2mg | EUR 95 |
Description: Prodrug of doxorubicin |
DOXO-EMCH |
|||
A3372-5 | ApexBio | 5 mg | EUR 158 |
Description: Prodrug of doxorubicin |
DOXO-EMCH |
|||
A3372-50 | ApexBio | 50 mg | EUR 806 |
Description: Prodrug of doxorubicin |
DOXO-EMCH |
|||
ADC-P-145 | Creative Biolabs | unit | Ask for price |
Doxofylline |
|||
329005 | MedKoo Biosciences | 1.0g | EUR 175 |
Doxofylline |
|||
D557100 | Toronto Research Chemicals | 50g | EUR 138 |
Description: 69975-86-6 |
Doxofylline |
|||
B1734-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 40 |
Description: PDE inhibitor |
Doxofylline |
|||
B1734-50 | ApexBio | 50 mg | EUR 32 |
Description: PDE inhibitor |
Doxofylline |
|||
HY-B0004 | MedChemExpress | 100mg | EUR 142.8 |
Doxofylline |
|||
T0480-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxofylline |
Doxofylline |
|||
T0480-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxofylline |
Doxofylline |
|||
T0480-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxofylline |
Doxofylline |
|||
T0480-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxofylline |
Doxofylline |
|||
T0480-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxofylline |
Anti-FUT3 (clone cBR96)-hydrazone-doxorubicin ADC |
|||
ADC-W-423 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-FUT3 monoclonal antibody (clone cBR96) conjugated via a hydrazone linker to adoxorubicin |
Doxofylline-d4 |
|||
D557102 | Toronto Research Chemicals | 25mg | EUR 1200 |
Description: 1346599-13-0 |
Anti-CD70 (clone h1F6)-β-glucuronide-doxorubicin ADC |
|||
ADC-W-376 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-CD70 monoclonal antibody (clone h1F6) conjugated via a β-glucuronide linker to a doxorubicin |
Doxofylline-d6 (dimethyl-d6) |
|||
D557101 | Toronto Research Chemicals | 10mg | EUR 339 |
Description: 1219805-99-8 |
Anti-TNFRSF8 (cCA10)-β-glucuronide-doxorubicin propyloxazoline (DPO) ADC |
|||
ADC-W-353 | Creative Biolabs | 1mg | Ask for price |
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (cCA10) conjugated via a β-glucuronide linker to a doxorubicin propyloxazoline (DPO) |
Doxycycline Ezy MIC Strip DOX (0.016-256 |
|||
EM103-10ST | EWC Diagnostics | 1 unit | EUR 23.69 |
Description: Doxycycline Ezy MIC Strip DOX (0.016-256 |
Doxycycline Ezy MIC Strip DOX (0.016-256 |
|||
EM103-120ST | EWC Diagnostics | 1 unit | EUR 154.74 |
Description: Doxycycline Ezy MIC Strip DOX (0.016-256 |
Bojanus grew to become a professor of zoology in 1806 and a professor of comparative anatomy in 1814 at Vilnius College, the place, amongst different accomplishments, he established himself as a founder of recent veterinary medication and a pioneer of pre-Darwinian and pre-Lamarckian evolutionism.